BRAF and colorectal carcinoma: On the basis of the collected microarrays, we found that the subgroup with low PPM1H expression was characterised by high levels of VIM expression and that this group significantly overlapped with the subset with MSI or BRAF mutations, indicating that PPM1H is potentially involved in the aggressiveness of CRC.